Vahur Valvere

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

Magdolna Dank, J. Załuski, Carlo Barone et al. · Annals of Oncology · 2008 · 343 citations · Full text

Medicine, Oncology, Pharmacology +13

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group

J Sjöström, Carl Blomqvist, Henning T. Mouridsen et al. · European Journal of Cancer · 1999 · 269 citations

Medicine, Oncology, Pharmacology +16

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study

Carmelo Pozzo, C. Barone, J. Szántó et al. · Annals of Oncology · 2004 · 157 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.

Johanna Sjöström, Carl Blomqvist, Kristina von Boguslawski et al. · PubMed · 2002 · 144 citations

Medicine, Oncology, Pharmacology +15

Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1^st-line advanced gastric cancer patients

Magdolna Dank, J. Załuski, C. Barone et al. · Journal of Clinical Oncology · 2005 · 87 citations

Medicine, Oncology, Pharmacology +5